title: Despite slow progress, bispecifics generate buzz.
authors.forename: Cormac
authors.initials: C
authors.lastname: Sheridan
mesh_terms: D018033:Antibodies, Bispecific / Q000191:economics / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D055808:Drug Discovery / Q000191:economics*; D006801:Humans; D058990:Molecular Targeted Therapy
chemical_list: D018033:Antibodies, Bispecific